Skip to main content

PRODUCCIÓN DE PROTEINAS TERAPEUTICAS EN BIOFACTORIAS VEGETALES. PROTEBIOV.

IPT-2011-0720-010000

•
Funding agency name Ministerio de Ciencia e Innovación
Funding agency acronym MICINN
Program Programa Nacional de Cooperación Público-Privada
Subprogram Subprograma INNPACTO
Call INNPACTO
Call year 2011
State Plan 2008-2011 Plan Nacional de Investigación Científica, Desarrollo e Innovación Tecnológica
Management unit Subdirección General de Estrategias de Colaboracion Publico-Privada
Beneficiary centre 3P BIOPHARMACEUTICALS SL

PRODUCCIÓN DE PROTEINAS TERAPEUTICAS EN BIOFACTORIAS VEGETALES. PROTEBIOV.

IPT-2011-0720-010000

•
Funding agency name Ministerio de Ciencia e Innovación
Funding agency acronym MICINN
Program Programa Nacional de Cooperación Público-Privada
Subprogram Subprograma INNPACTO
Call INNPACTO
Call year 2011
State Plan 2008-2011 Plan Nacional de Investigación Científica, Desarrollo e Innovación Tecnológica
Management unit Subdirección General de Estrategias de Colaboracion Publico-Privada
Beneficiary centre 3P BIOPHARMACEUTICALS SL

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

A coat-independent superinfection exclusion rapidly imposed in Nicotiana benthamiana cells by tobacco mosaic virus is not prevented by depletion of the movement protein

  • Julve Parreño, Jose Manuel
  • Gandia Fernàndez, Antoni
  • Sarrion-Perdigones, Alejandro
  • Castelijns, Bas
  • Fernandez Del Carmen, Maria Asuncion|||0000-0002-9202-4960
  • GRANELL RICHART, ANTONIO|||0000-0003-4266-9581
  • Orzáez Calatayud, Diego Vicente
[EN] New evidence is emerging which indicates that population variants in plant virus infections are not uniformly distributed along the plant, but structured in a mosaic-like pattern due to limitation to the superinfection imposed by resident viral clones. The mechanisms that prevent the infection of a challenge virus into a previously infected cell, a phenomenon known as superinfection exclusion (SE) or Homologous Interference, are only partially understood. By taking advantage of a deconstructed tobacco mosaic virus (TMV) system, where the capsid protein (CP) gene is replaced by fluorescent proteins, an exclusion mechanism independent of CP was unveiled. Time-course superinfection experiments provided insights into SE dynamics. Initial infection levels affecting less than 10 % of cells led to full immunization in only 48 h, and measurable immunization levels were detected as early as 6 h post-primary infection. Depletion of a functional movement protein (MP) was also seen to slow down, but not to prevent, the SE mechanism. These observations suggest a CP-independent mechanism based on competition for a host-limiting factor, which operates at very low virus concentration. The possible involvement of host factors in SE has interesting implications as it would enable the host to influence the process., We wish to acknowledge Dr. Victor Klimyuk and Dr. Yuri Gleba from ICON-Genetics for kindly providing the MagnICON vectors. Thanks also to Dr. George Lomonossof for providing the pEAQ vectors. This work was supported by Projects BIO2010-15384 and IPT-2011-0720-010000 from the Spanish Ministry of Economy and Competitiveness.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

A synthetic biology approach for consistent production of plant-made recombinant polyclonal antibodies against snake venom toxins

  • Julve Parreño, Jose Manuel
  • Huet, Estefania
  • Fernandez-del-Carmen, Asun
  • Segura, Alvaro
  • Venturi, Micol
  • Gandia, Antoni
  • Pan, Wei-song
  • Albaladejo, Irene
  • Pla, Davinia
  • Wigdorovitz, Andrés
  • Calvete, Juan J.
  • Gutierrez, Carlos
  • Gutiérrez, José María
  • Forment Millet, José Javier|||0000-0002-1872-4061
  • GRANELL RICHART, ANTONIO|||0000-0003-4266-9581
  • Orzáez Calatayud, Diego Vicente
[EN] Antivenoms developed from the plasma of hyperimmunized animals are the only effective treatment available against snakebite envenomation but shortage of supply contributes to the high morbidity and mortality toll of this tropical disease. We describe a synthetic biology approach to affordable and cost-effective antivenom production based on plant-made recombinant polyclonal antibodies (termed pluribodies). The strategy takes advantage of virus superinfection exclusion to induce the formation of somatic expression mosaics in agroinfiltrated plants, which enables the expression of complex antibody repertoires in a highly reproducible manner. Pluribodies developed using toxin-binding genetic information captured from peripheral blood lymphocytes of hyperimmunized camels recapitulated the overall binding activity of the immune response. Furthermore, an improved plant-made antivenom (plantivenom) was formulated using an invitro selected pluribody against Bothrops asper snake venom toxins and has been shown to neutralize a wide range of toxin activities and provide protection against lethal venom doses in mice., We thank Brian J. Robinson for his careful revision of the manuscript. The work carried out at IBMCP-CSIC received financial support from MINECO and ERDF (project grants IPT-2011-0720-010000, BIO2013-42193-R and BIO2016-78601-R). Research at IBV-CSIC was supported by grant BFU2013-42833-P from the Spanish Ministry of Economy and Competitiveness, Madrid, Spain. The authors declare no conflict of interest